Taro Pharmaceutical Industries Ltd (TARO)
NYSE
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End March 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | 20.383 | 8.941 | 12.336 | 10.912 | -16.287 | 2.543 | 1.18 | 2.507 |
| Return on Equity (%) | 22.756 | 9.857 | 13.673 | 12.149 | -20.322 | 3.42 | 1.478 | 3.057 |
| Return on Invested Capital (%) | 22.088 | 11.137 | 13.567 | 13.181 | -33.706 | 4.182 | 0.823 | 0.055 |
| Operating Margin (%) | 63.786 | 44.216 | 53.309 | 46.336 | -70.989 | 14.164 | 6.888 | 13.139 |
| Net Profit Margin (%) | 51.895 | 31.9 | 42.063 | 37.88 | -70.432 | 10.38 | 4.441 | 8.561 |
| Book Value Per Share | 50.861 | 55.695 | 49.169 | 54.733 | 44.333 | 43.958 | 43.898 | 47.243 |
| Earnings Per Share | 11.264 | 5.355 | 7.311 | 6.384 | -10.194 | 1.55 | 0.677 | 1.433 |
| Cash Per Share | 14.819 | 14.623 | 14.723 | 13.417 | 15.956 | 6.681 | 4.11 | 9.655 |
| Working Capital Per Share | 44.16 | 42.628 | 32.845 | 34.235 | 20.948 | 24.097 | 25.297 | 25.069 |
| Operating Profit Per Share | 16.94 | 12.173 | 12.143 | 11.006 | 8.446 | 8.488 | 7.993 | 8.941 |
| EBIT Per Share | 13.841 | 7.415 | 9.259 | 7.79 | -10.311 | 2.071 | 1.017 | 2.199 |
| EBITDA Per Share | 13.841 | 7.415 | 9.259 | 7.79 | -10.311 | 2.071 | 1.017 | 2.199 |
| Free Cash Flow Per Share | 11.782 | 5.686 | 20.597 | 6.567 | -10.366 | 1.181 | 0.298 | 2.048 |
| Year End March 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 40.51M | 39.43M | 38.54M | 38.26M | 37.93M | 37.59M | 37.59M | 37.59M |
| Year End March 30 2024 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 37.59M | 37.59M | 37.59M | 37.59M | 37.59M | 37.59M | 37.59M | 37.59M |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | 10.247 | N/A | N/A | N/A | 3.424 | N/A | N/A | N/A |
| Net Profit Margin (%) | 8.987 | N/A | N/A | N/A | 6.314 | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 1.61B |
| Price to Earnings Ratio | 29.98 |
| Price to Sales Ratio | 2.57 |
| Price to Cash Ratio | 4.45 |
| Price to Book Ratio | 0.9 |
| Dividend Yield | - |
| Shares Outstanding | 37.58M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
